Search

everythinglearnresearchcommunity

for

Search:↓

New insights into cell communication in psoriasis suggest innovative drug treatments.

TLR3 activation helps improve skin and hair follicle healing in mice.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

CGF therapy may effectively treat psoriasis by reducing inflammation.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

The excimer laser may help hair regrow in alopecia areata patients.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Hair follicle cells help maintain and support stem cells and blood cell formation.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Removing REDD1 in mice increases skin fat by making fat cells larger and more numerous.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.